Related Experiment Video
Updated: Nov 15, 2025

Predictive Measurement for Windlass Change in Length and Selected Treatment Outcomes in Chronic Plantar Fasciitis
Published on: March 1, 2024
Race reporting and representation in onychomycosis clinical trials: A systematic review
Michelle J Chang1, Yuqing Qiu2,3, Shari R Lipner3
1Drexel University College of Medicine, Philadelphia, PA, USA.
Background:
Onychomycosis is the most common nail disease seen in clinical practice. Inclusion of diverse groups in onychomycosis clinical trials subjects is necessary to generalise efficacy data.
Objectives:
We aimed to systematically review race and ethnicity reporting and representation, as well as, treatment outcomes in onychomycosis clinical trials.
Methods:
A PubMed search for onychomycosis clinical trials was performed in August 2020. Primary clinical trial data were included and post hoc analyses were excluded. Categorical variables were compared using chi-squared and Fisher's exact tests. Statistical significance was set at p < .05. Photos in articles were categorised by Fitzpatrick skin type.
Results:
Only 32/182 (17.5%) trials reported on race and/or ethnicity and only one trial compared treatment efficacy in different subgroups. Darker skin colours were infrequently depicted in articles. Topical treatment, location with ≥1 US-based site, industry funding type and publication date after 2000 were significantly associated with reporting of racial/ethnic data (p < .05 for all comparisons).
Limitations:
Demographics on excluded subjects and methods of recruitment were not available. Assigning Fitzpatrick skin type is inherently subjective.
Conclusions:
This study highlights a need for consistent reporting of races and ethnicities of onychomycosis clinical trial participants with subgroup analyses of treatment efficacies.
Insights
Reporting of race and ethnicity in onychomycosis clinical trials is poor, hindering generalizability. Consistent demographic data and subgroup analyses are needed to ensure treatment efficacy is understood across diverse populations.
Area of Science:
- Dermatology
- Clinical Trials
- Health Disparities
Background:
- Onychomycosis is a prevalent nail condition.
- Diverse participant inclusion in clinical trials is crucial for generalizable efficacy data.
Purpose of the Study:
- To systematically review race and ethnicity reporting in onychomycosis clinical trials.
- To assess representation and treatment outcomes across different demographic groups.
Main Methods:
- PubMed search conducted in August 2020 for onychomycosis clinical trials.
- Analysis of primary clinical trial data, excluding post hoc studies.
- Categorical variables compared using chi-squared and Fisher's exact tests; photos categorized by Fitzpatrick skin type.
Main Results:
- Only 17.5% of trials reported race/ethnicity data; one trial compared subgroup efficacy.
- Darker skin tones were rarely depicted.
- Reporting was associated with topical treatments, US-based sites, industry funding, and post-2000 publications.
Conclusions:
- Inconsistent reporting of participant demographics limits understanding of treatment efficacy.
- There is a need for standardized reporting of race and ethnicity in onychomycosis trials.
- Subgroup analyses are essential for evaluating treatment outcomes in diverse populations.
Related Concept Videos
Clinical Trials: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...
Changes in Skin Color: Clinical Perspectives
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Bias in Epidemiological Studies

